Indoco Remedies Transfers Ophthalmic Division to Sunways

• Indoco Remedies Board approved transfer of its ophthalmic business to Sunways India via an Agreement to Transfer Business.
• The transaction covers the territories of India and select African markets, sharpening Indoco's focus on core therapeutic areas.
• Sunways India will strengthen its ophthalmology platform by adding Indoco's established operating business and product portfolio.
• The deal involves transfer of an operating division but specific financial terms or valuation were not disclosed in the release.